688321.SH
微芯生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 25.89
−7.37%Margins
Gross margin
87.0%
EBITDA margin
12.0%
EBIT margin
9.7%
Net margin
9.8%
FCF margin
-16.0%
3.8%
Return on equity
2.1%
Return on assets
3.0%
Return on invested capital
0.24x
Asset turnover
CNY 101.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026